Moderna Inc said its experimental vaccine was 94.5% effective in preventing COVID-19, a week after Pfizer Inc reported positive results from its own late-stage trial.At 7:15 am ET, Dow e-minis were up 514 points, or 1.74%, and S&P 500 e-minis were up 41.25 points, or 1.15%.
Nasdaq 100 e-minis erased early gains to trade down 2.5 points, or -0.02%.Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company's still ongoing study.
A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the US.Dr Stephen Hoge, Moderna's president, welcomed the “really important.